Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Amble

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Amble head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 103 · Grade C

Amble

Visit Amble Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 74 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Amble a bad call — it's best for patients comfortable with online care who will check the full plan term and pharmacy-processing deadline before paying. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
74
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
79
Track Record
88
77
CoreAge RxBrief Score 94 · 74Amble

Price, coverage & the tracker

CoreAge RxAmble
Brief Score94/100 (A)74/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm current price

Earlier listing: From $179/mo (starting dose, compounded) (checked July 2026).

Confirm the medication, billing term and full charge before paying.

Full price details

Current medication quote unknown; earlier listing: From $179/mo (starting dose, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm current price

Earlier listing: From $289/mo (starting dose, compounded) (checked July 2026).

Confirm the medication, billing term and full charge before paying.

Full price details

Current medication quote unknown; earlier listing: From $289/mo (starting dose, compounded)

CoverageUS only; restrictions by state, confirmed at intakeAll 50 states advertised with exclusions; confirm medication-specific eligibility
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Amble: Confirm the current drug-specific charge, full commitment and pharmacy-processing deadline. The grid shows its price-check date; generic GLP-1 offers are not interchangeable quotes.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.